Company Name | Galecto Biotech |
---|---|
Website | https://galecto.com |
Snippet | (COPENHAGEN - May 21, 2018) - Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the appointment of Richard Marshall, MD, PhD, as Chief Medical Officer. |
Country | denmark |
Founded | 2011.0 |
Website | galecto.com |
Industry | biotechnology |
linkedin.com/company/galecto-biotech | |
size_range | 11 - 50 |
display_url | galecto.com |
Headquarters | copenhagen, capital region, denmark |
Number of employees | 6 |
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us